A randomized double-blind controlled clinical trial demonstrating efficacy of different probiotic strains on serum lipids and glycemic biomarker.
- 2024-08-01
- RCT · n = 51
- Nutricion hospitalaria 41(4)
- Gözde Okburan
- Murat Baş
- Sultan Ogmen
- PubMed: 38967303
- DOI: 10.20960/nh.04724
- High evidence
- Clinical
both intervention groups significantly alter the HOMA-IR values compared to the placebo group (p < 0.05).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 1 × 10^6 CFU/day